| - Industry | - Sector | Mr. Sanjeev Choudhary CEO | XFRA Exchange | PLMDNCE00016 ISIN |
| PL Country | 11 Employees | - Last Dividend | - Last Split | - IPO Date |
Medinice S.A. is a medical technology company that specializes in creating, developing, and commercializing minimally invasive solutions in the fields of cardiology and cardiac surgery. Based in Warsaw, Poland, the company was founded in 2012 and has established itself in the market by providing innovative medical devices aimed at improving patient outcomes and reducing the risk of complications associated with cardiac procedures.
PacePress is a medical device designed to minimize the risk of complications after the implantation of cardiac electrotherapeutic devices, such as pacemakers and implantable cardioverter-defibrillators. Its innovative design enhances patient safety during these critical procedures.
CoolCryo is a cutting-edge cardiac cryoablation technology that utilizes liquid nitrogen as the cooling medium. This technology is crucial for effectively targeting and treating abnormal heart rhythms through precise cryoablation techniques.
AtriClamp is a specialized clip designed for closing the left atrial appendage, helping to significantly reduce the risk of stroke in patients suffering from atrial fibrillation. This product is an important advancement in enhancing the safety of cardiac patients.
MiniMax is an ablation-mapping catheter that facilitates the detection of intracardiac electrophysiological signals. It allows for the creation of a three-dimensional map of the heart, enabling clinicians to perform intracardiac irrigated radiofrequency ablation for treating arrhythmias caused by conduction system abnormalities.
EP Bioptom is an advanced electrode designed for endomyocardial biopsy procedures. This device leverages 3D mapping technology, allowing healthcare professionals to conduct simultaneous biopsies while creating a comprehensive three-dimensional heart map for better diagnostic accuracy.